ArticleJournal of translational medicine2023

CBX3 promotes clear cell renal carcinoma through PI3K/AKT activation and aberrant immunity.

Jiasheng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.